REDEFINING VASCULAR INTERVENTIONS
Corindus, A Siemens Healthineers Company, is a global technology leader in robotic-assisted vascular interventions. The Company’s CorPath® platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. CorPath GRX is the second-generation robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. We are focused on developing innovative robotic solutions to revolutionize treatment of emergent conditions by providing specialized and timely medical care to patients around the world.
For additional information, visit www.corindus.com, and follow @CorindusInc.
Fast Company named Corindus one of the “World’s Most Innovative Companies of 2021”. See the full list here and read the press release.